Heading is an Austin-based mental health company founded in 2020 by Co-founder Steve Levine, MD and CEO, Simon Tankel. By combining evidence-based practices, personalized treatment plans, and a commitment to patient-centric care, Heading is transforming the mental health landscape and providing lasting relief to those in need. Today Heading offers a continuum of in-network mental health services for hard to treat conditions including interventional psychiatric services like intramuscular ketamine, Spravato®, and TMS in their centers, along with psychiatry and therapy conveniently available through telehealth. Heading has locations in the Austin and Dallas-Forth Worth metros, with plans for further expansion in Dallas and a first location in Houston later this year.